ArticleThe Korean journal of internal medicine2022

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors.

Juwhan Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.